Utomilumab

Utomilumab (PF 05082566) is a humanized IgG2 antibody targeting the T-cell co-stimulatory receptor 4-1BB/CD137 and a 4-1BB/CD137 agonist.Utomilumab has antitumor activity and may be used in the study of patients with advanced malignancies.

Price Not Available 5 mg Utomilumab Supplier Page

Catalog Number	T76705
Alternative Name(s)	PF 05082566 , PF-2566
Research Area	Apoptosis
Molecular Formula	C17H24N8O3
CAS#	1417318-27-4
Size	5 mg
Supplier Page	https://www.targetmol.com/compound/utomilumab
Additional Information	https://www.targetmol.com/datasheet/T76705